Skip to main content
Terug
Watch Compare

Forte Biosciences, Inc.

Datakwaliteit: 83%
FBRX
Nasdaq Manufacturing Chemicals
€ 35,09
▲ € 1,19 (3,51%)
Marktkapitalisatie: 472,11 M
Prijs
€ 34,00
Marktkapitalisatie
472,11 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -51,00 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-75,94%
Onder sectorgemiddelde (-53,53%)
ROIC-61,10%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio7,34
Interest Coverage-26,02

Waardering

PE (TTM)
-6,81
Onder sectorgemiddelde (-1,48)
P/B Ratio5,61
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -6,8 -1,5
P/B 5,6 1,6
ROE % -75,9 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

4 analisten
Buy
Huidig
€ 35,09
+81.7%
Koersdoel
€ 63,75
€ 54,00
€ 63,00
€ 75,00
Vooruitzicht
Forward K/W -8,12
Forward WPA -€ 4,32
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 4,32
-€ 5,25 – -€ 3,26
 0,0 5
FY2026 -€ 4,34
-€ 4,78 – -€ 3,87
 0,0 5

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,15 -€ 1,45 -26,4%
Q32025 -€ 1,07 -€ 0,99 +7,3%
Q22025 -€ 1,11 -€ 0,96 +13,3%
Q12025 -€ 0,95 -€ 1,37 -44,2%

ETFs Holding This Stock

AHSCX AHSCX
5,49% weight
AHSAX AHSAX
5,49% weight
AHSZX AHSZX
5,49% weight
AASOX AASOX
2,41% weight
ATVPX ATVPX
1,44% weight
AGSCX AGSCX
0,82% weight
ASCYX ASCYX
0,82% weight
ASCZX ASCZX
0,82% weight
ALSCX ALSCX
0,82% weight
ALSAX ALSAX
0,82% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -69,38 M
ROE -75,94% ROA -67,73%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,00 M
ROIC -61,10% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7,34
Interest Coverage -26,02 Asset Turnover N/A
Working Capital 82,42 M Tangible Book Value 84,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,81 Forward P/E N/A
P/B Ratio 5,61 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,80%
Market Cap 472,11 M Enterprise Value 378,70 M
Per Share
EPS (Diluted TTM) -4,71 Revenue / Share N/A
FCF / Share -3,67 OCF / Share -3,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 73,51%
SBC-Adj. FCF -56,38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -69,38 M -35,48 M -31,48 M -13,88 M -21,71 M
EPS (Diluted) -4,71 -12,17 -1,00 -0,80 —
Gross Profit — — — — —
Operating Income -70,66 M -36,60 M -32,49 M -13,90 M -21,49 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,72 M 1,31 M 1,12 M — —
Income Tax 1,04 M — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 82,78 M 61,56 M 38,98 M 42,00 M 43,31 M
Total Liabilities 21,79 M — — — —
Shareholders' Equity 60,99 M 52,48 M 35,31 M 38,82 M 41,55 M
Total Debt — — — — —
Cash & Equivalents 76,96 M 22,24 M 37,13 M 41,10 M 42,04 M
Current Assets 80,59 M 61,35 M 38,33 M 41,51 M 42,52 M
Current Liabilities 20,75 M 9,08 M 3,67 M 3,18 M 1,76 M